Disease Attributes  >>  Cytovene (ganciclovir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cytovene (ganciclovir) / Roche
NCT01503918 / 2010-024646-30: Cytomegalovirus Control in Critical Care

Completed
2
124
Europe
Valaciclovir/Aciclovir, Valganciclovir/Ganciclovir
University Hospital Birmingham NHS Foundation Trust, National Institute for Health Research, United Kingdom
Critical Illness
01/14
03/14

Download Options